Urology News and Research

Latest Urology News and Research

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

For about the last 25 years, the cardiology group here have been developing a platform technology for both the diagnosis and treatment of atherosclerosis.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 28 Oct 2015

Praziquantel treatment safe for pregnant women after first trimester

A study by Rhode Island Hospital researchers confirmed that a drug used to treat a disease afflicting millions of people in developing countries is safe to give pregnant women following their first trimester. The finding could prove critical to the care of pregnant women and lactating women with schistosomiasis, a disease caused by a parasitic worm, who were denied the drug out of concern for their health and the health of their fetuses.

28 Oct 2015

PRN Course for rehabilitation nurses now available online

The PRN Course is an intensive, online course covering the major areas of care that a rehabilitation nurse provides and is conveniently accessible from anywhere. Recorded at the recent live course, this valuable educational opportunity addresses comprehensive care for the rehabilitation patient, including how professionals can incorporate 36 rehabilitation nursing concepts and skills into their practice.

26 Oct 2015

Hitachi presents new ultrasound platform at United European Gastroenterology Week

Ultrasound diagnosis is an indispensable tool for a variety of clinical applications and users have high expectations that challenge modern, powerful ultrasound platforms. With the new brand ARIETTA , Hitachi presents a new solution that meets these demands.

26 Oct 2015

New approaches to treating lung cancer patients in New Mexico

This year, more than 158,000 Americans are expected to die from lung cancer. That's a staggering number: it's more than all the deaths expected from breast, prostate, colon, rectum, bladder and skin cancers combined.

26 Oct 2015

Smartphone app may improve self-management skills in young patients with spina bifida

A system incorporating a smartphone app may help adolescents and young adults with spina bifida to improve their daily self-management skills, suggests a paper in the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists. The journal is published by Wolters Kluwer.

23 Oct 2015

Intense education program can reduce use of indwelling urinary catheters in MICU setting

Many hospitalized patients have an indwelling urinary catheter (IUC), and previous studies have found up to one-third of IUCs are unneeded. A team of researchers from Maimonides Medical Center in Brooklyn, New York, implemented an intervention that decreased the use of IUCs in patients from 92.3 percent to just 15 percent, representing a 77.3 percent reduction in use.

20 Oct 2015

ESPU, ICCS launch World Bedwetting Day to raise awareness among children and families

The International Children’s Continence Society and the European Society for Paediatric Urology announced today the launch of World Bedwetting Day at the 26th ESPU Congress in Prague.

20 Oct 2015

Allergan completes acquisition of AqueSys

Allergan plc, a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma.

19 Oct 2015

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Sprout Pharmaceuticals, Inc., a division of Valeant Pharmaceuticals North America LLC, announced today that Addyi, a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, is now available in the United States through certified physicians and pharmacies.

19 Oct 2015

Synapse Biomedical, IFR to commercialize implantable systems that restore muscle function in paralyzed patients

Case Western Reserve University's Institute for Functional Restoration (IFR) and Synapse Biomedical Inc. have entered a partnership to commercialize fully implantable systems that restore muscle function in paralyzed patients.

16 Oct 2015

ADMT announces filing of FDA 510(k) application for Angiodroid The CO2 Injector for Angiography

ADM Tronics Unlimited, Inc. has announced that a Premarket Notification 510(k) application has been filed with the US Food and Drug Administration for Angiodroid The CO2 Injector for Angiography (the "Angiodroid Injector") by Angiodroid America, Inc., a subsidiary of Angiodroid, Srl, in affiliation with Triotech Ventures and ADMT, as previously announced.

15 Oct 2015

SonaCare Medical's Sonablate 450 focused ultrasound system receives FDA approval for ablation of prostate tissue

The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined prostate disease while preserving surrounding healthy tissue, without radiation or surgery.

14 Oct 2015

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Eli Lilly and Company and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

13 Oct 2015

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

A pioneering surgical technique has restored some hand and arm movement to patients immobilized by spinal cord injuries in the neck, reports a new study at Washington University School of Medicine in St. Louis.

12 Oct 2015

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

Allergan plc today announced that its infectious disease portfolio will be featured in 13 abstracts highlighting data at IDWeek 2015, which takes place from October 7-11, 2015, in San Diego.

8 Oct 2015

Myriad Genetics and Tufts Health Plan sign agreement to cover Prolaris® for members with localized prostate cancer

Myriad Genetics, Inc. (NASDAQ: MYGN) has announced that it has signed a three-year contract with Tufts Health Plan through which the plan will provide coverage of Prolaris® for members diagnosed with localized prostate cancer. Prolaris is the first and only biopsy test validated against prostate cancer specific mortality.

7 Oct 2015

Urology News and Research

Latest Urology News and Research

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

Praziquantel treatment safe for pregnant women after first trimester

PRN Course for rehabilitation nurses now available online

Hitachi presents new ultrasound platform at United European Gastroenterology Week

New approaches to treating lung cancer patients in New Mexico

Smartphone app may improve self-management skills in young patients with spina bifida

Intense education program can reduce use of indwelling urinary catheters in MICU setting

ESPU, ICCS launch World Bedwetting Day to raise awareness among children and families

Allergan completes acquisition of AqueSys

Sprout announces U.S. availability of Addyi for HSDD treatment in premenopausal women

Synapse Biomedical, IFR to commercialize implantable systems that restore muscle function in paralyzed patients

ADMT announces filing of FDA 510(k) application for Angiodroid The CO2 Injector for Angiography

SonaCare Medical's Sonablate 450 focused ultrasound system receives FDA approval for ablation of prostate tissue

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

Allergan's anti-infective portfolio to be highlighted at IDWeek 2015

Myriad Genetics and Tufts Health Plan sign agreement to cover Prolaris® for members with localized prostate cancer

Study identifies five resources that can help hospitals improve surgeries on weekends

Recipients of 2015 Ferring Innovation Grants announced

Quest Diagnostics provides PD-L1 IHC 22C3 PharmDx test service for NSCLC patients

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Urology News and Research

Latest Urology News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in